Fig. 3From: N6-Methyladenosine RNA modification in cerebrospinal fluid as a novel potential diagnostic biomarker for progressive multiple sclerosisFunctional annotation of the DEGs between MS and non-MS patients. a The integrated analysis of gene-protein interactions of top 94 DEGs and m6A-related genes. b, c The enriched GO terms of these m6A-related genes and DEGs. d The significant KEGG pathways of these m6A-related genes and DEGs. e The PPI network of these m6A-related genes with high confidence (> 0.7)Back to article page